From a medical cardiologist’s perspective, why is the mandate to lower LDL-C level so important for reducing CV risk? How low do recommend lowering the LDL-C level? Where do the PCSK9 inhibitors fit into the overall sequencing strategy?

From a medical cardiologist’s perspective, why is the mandate to lower LDL-C level so important for reducing CV risk? How low do recommend lowering the LDL-C level? Where do the PCSK9 inhibitors fit into the overall sequencing strategy?

CLICK HERE FOR CME CREDIT

From a medical cardiologist’s perspective, why is the mandate to lower LDL-C level so important for reducing CV risk? How low do recommend lowering the LDL-C level? Where do the PCSK9 inhibitors fit into the overall sequencing strategy?

Created by

CMEducation Resources IQ&A Cardiovascular Intelligence Zone | The Medical and Preventive Cardiologist's Perspective

Presenter

Samuel Goldhaber, MD

Samuel Goldhaber, MD

Section Head, Vascular Medicine Director, Thrombosis Research Group Cardiovascular Medicine Brigham and Women’s Hospital Professor of Medicine Harvard Medical School Boston, MA USA